Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
PagerDuty price target raised to $53 from $43 at Baird » 08:47
01/26/21
01/26
08:47
01/26/21
08:47
PD

PagerDuty

$48.09 /

-0.8 (-1.64%)

Baird analyst Rob Oliver…

Baird analyst Rob Oliver raised the firm's price target on PagerDuty to $53 from $43 and keeps an Outperform rating on the shares. The target increase comes after checks suggest continued improvement in spending trends in the IT suite which should benefit the company.

ShowHide Related Items >><<
PD PagerDuty
$48.09 /

-0.8 (-1.64%)

PD PagerDuty
$48.09 /

-0.8 (-1.64%)

01/20/21 Berenberg
PagerDuty upgraded to Buy from Hold at Berenberg
01/04/21 Craig-Hallum
PagerDuty price target raised to $52 from $45 at Craig-Hallum
12/04/20 JPMorgan
PagerDuty price target raised to $45 from $31 at JPMorgan
12/04/20 Truist
PagerDuty price target raised to $30 from $20 at Truist
PD PagerDuty
$48.09 /

-0.8 (-1.64%)

PD PagerDuty
$48.09 /

-0.8 (-1.64%)

PD PagerDuty
$48.09 /

-0.8 (-1.64%)

Recommendations
Marvell price target raised to $60 from $50 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
MRVL

Marvell

/

+

Barclays analyst Blayne…

Barclays analyst Blayne Curtis raised the firm's price target on Marvell Technology Group to $60 from $50 and keeps an Overweight rating on the shares. The analyst increased price targets across the semiconductor capital equipment sector. While valuations "definitely feel uncomfortable," the companies offer beat and raises across the board and good visibility into Q2 given shortages, Curtis tells investors in a research note.

ShowHide Related Items >><<
MRVL Marvell
/

+

MRVL Marvell
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
Marvell price target raised to $64 from $50 at Citi
01/15/21 Susquehanna
Marvell price target raised to $60 from $54 at Susquehanna
01/13/21 Piper Sandler
Marvell price target raised to $60 from $50 at Piper Sandler
MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

Yesterday
On The Fly
Fly Intel: After-Hours Movers » 18:53
01/25/21
01/25
18:53
01/25/21
18:53
IPAR

Inter Parfums

$60.50 /

+1.41 (+2.39%)

, GGG

Graco

$74.74 /

-1.17 (-1.54%)

, FUL

H.B. Fuller

$50.80 /

-1.98 (-3.75%)

, WSFS

WSFS Financial

$46.04 /

-0.5 (-1.07%)

, HXL

Hexcel

$47.09 /

-1.235 (-2.56%)

, STLD

Steel Dynamics

$38.37 /

-0.35 (-0.90%)

, BDGE

Bridge Bancorp

$27.19 /

-0.08 (-0.29%)

, STAA

Staar Surgical

$89.69 /

-1.69 (-1.85%)

, IAC

IAC

$202.84 /

+1.83 (+0.91%)

, NBTX

Nanobiotix

$17.47 /

-1.25 (-6.68%)

, BCRX

BioCryst

$9.15 /

-0.06 (-0.65%)

, JJSF

J & J Snack Foods

$156.47 /

+3.58 (+2.34%)

, CR

Crane

$78.60 /

-2.15 (-2.66%)

, KRMD

Koru Medical

$5.13 /

-0.06 (-1.16%)

, QUMU

Qumu

$8.11 /

-0.32 (-3.80%)

, SEEL

Seelos Therapeutics

$2.65 /

+0.07 (+2.71%)

, CVAC

CureVac

$104.31 /

+2.31 (+2.26%)

, ASO

Academy Sports

$23.70 /

+1.28 (+5.71%)

Check out this evening's…

ShowHide Related Items >><<
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

SEEL Seelos Therapeutics
$2.65 /

+0.07 (+2.71%)

NBTX Nanobiotix
$17.47 /

-1.25 (-6.68%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

GGG Graco
$74.74 /

-1.17 (-1.54%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

CR Crane
$78.60 /

-2.15 (-2.66%)

BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

12/02/20 DA Davidson
Inter Parfums price target lowered to $50 from $55 at DA Davidson
11/11/20 DA Davidson
Inter Parfums price target raised to $55 from $39 at DA Davidson
11/11/20 Citi
Inter Parfums price target raised to $56 from $46 at Citi
08/12/20 BWS Financial
Inter Parfums upgraded to Buy from Neutral at BWS Financial
GGG Graco
$74.74 /

-1.17 (-1.54%)

01/19/21 Jefferies
Graco upgraded to Buy from Hold at Jefferies
10/23/20 RBC Capital
Graco price target raised to $72 from $65 at RBC Capital
10/16/20 Berenberg
Graco initiated with a Hold at Berenberg
08/11/20
Fly Intel: Top five analyst upgrades
FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

01/04/21 Baird
H.B. Fuller upgraded to Outperform, added to 2021 top picks at Baird
01/04/21 Baird
H.B. Fuller upgraded to Outperform from Neutral at Baird
12/18/20
Fly Intel: Top five analyst upgrades
12/18/20 Citi
H.B. Fuller upgraded to Buy from Neutral at Citi
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

04/01/20 Keefe Bruyette
WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette
HXL Hexcel
$47.09 /

-1.235 (-2.56%)

01/21/21 Credit Suisse
Hexcel downgraded to Underperform from Neutral at Credit Suisse
01/21/21 Credit Suisse
Hexcel downgraded to Underperform from Neutral at Credit Suisse
12/15/20 KeyBanc
Hexcel downgraded to Sector Weight at KeyBanc
12/14/20 KeyBanc
Hexcel downgraded to Sector Weight from Overweight at KeyBanc
STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

12/09/20 Morgan Stanley
Steel Dynamics initiated with an Overweight at Morgan Stanley
10/21/20 BMO Capital
Steel Dynamics price target raised to $35 from $32 at BMO Capital
09/18/20 BMO Capital
Steel Dynamics price target raised to $32 from $29 at BMO Capital
07/29/20 Deutsche Bank
Steel Dynamics price target raised to $31 from $27 at Deutsche Bank
BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

12/16/20 Boenning & Scattergood
Bridge Bancorp downgraded to Neutral from Outperform at Boenning & Scattergood
11/13/20 DA Davidson
Bridge Bancorp upgraded to Buy from Neutral at DA Davidson
STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

01/19/21 Benchmark
Staar Surgical downgraded to Hold on valuation at Benchmark
01/19/21 Benchmark
Staar Surgical downgraded to Hold from Buy at Benchmark
11/09/20 Canaccord
Staar Surgical price target raised to $84 from $70 at Canaccord
10/26/20 Sidoti
Staar Surgical downgraded to Neutral from Buy at Sidoti
IAC IAC
$202.84 /

+1.83 (+0.91%)

01/25/21 Piper Sandler
IAC price target raised to $240 from $211 at Piper Sandler
01/14/21 Deutsche Bank
IAC price target raised to $230 from $165 at Deutsche Bank
01/12/21 Piper Sandler
IAC price target raised to $211 from $205 at Piper Sandler
01/08/21 Goldman Sachs
Goldman Sachs sees IAC news as positive for MGM Resorts
NBTX Nanobiotix
$17.47 /

-1.25 (-6.68%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

12/22/20 JMP Securities
BioCryst selloff today a buying opportunity, says JMP Securities
12/07/20 H.C. Wainwright
BioCryst price target raised to $14 from $13 at H.C. Wainwright
12/04/20 Piper Sandler
BioCryst receives on-time approval with 'clean' label, says Piper Sandler
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

05/12/20 CL King
J & J Snack Foods upgraded to Buy from Neutral at CL King
CR Crane
$78.60 /

-2.15 (-2.66%)

01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
01/07/21 DA Davidson
Crane cut to Neutral at DA Davidson on valuation
01/07/21 DA Davidson
Crane downgraded to Neutral from Buy at DA Davidson
10/07/20 DA Davidson
DA Davidson positive on Crane's Engineered Materials, PMT segments
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

01/25/21 Piper Sandler
Koru Medical downgraded to Neutral from Overweight at Piper Sandler
11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
QUMU Qumu
$8.11 /

-0.32 (-3.80%)

07/15/20 Craig-Hallum
Qumu price target raised to $5 from $4 at Craig-Hallum
06/30/20 Craig-Hallum
Qumu upgraded to Buy at Craig-Hallum after merger agreement termination
06/30/20 Craig-Hallum
Qumu upgraded to Buy from Hold at Craig-Hallum
02/12/20
Qumu downgraded to Neutral from Buy at Dougherty
SEEL Seelos Therapeutics
$2.65 /

+0.07 (+2.71%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
CVAC CureVac
$104.31 /

+2.31 (+2.26%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

10/27/20
Fly Intel: Top five analyst initiations
10/27/20 UBS
Academy Sports initiated with a Buy at UBS
10/27/20 Credit Suisse
Academy Sports initiated with an Outperform at Credit Suisse
10/27/20 JPMorgan
Academy Sports initiated with an Overweight at JPMorgan
WSFS WSFS Financial
$46.04 /

-0.5 (-1.07%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

STAA Staar Surgical
$89.69 /

-1.69 (-1.85%)

QUMU Qumu
$8.11 /

-0.32 (-3.80%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JJSF J & J Snack Foods
$156.47 /

+3.58 (+2.34%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

GGG Graco
$74.74 /

-1.17 (-1.54%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CR Crane
$78.60 /

-2.15 (-2.66%)

BDGE Bridge Bancorp
$27.19 /

-0.08 (-0.29%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

  • 28
    Jan
  • 26
    Jan
  • 27
    Jan
  • 28
    Jan
  • 20
    Jan
  • 11
    Dec
  • 02
    Oct
  • 14
    Aug
  • 19
    Jun
  • 28
    May
  • 12
    Mar
  • 11
    Feb
STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

QUMU Qumu
$8.11 /

-0.32 (-3.80%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IAC IAC
$202.84 /

+1.83 (+0.91%)

HXL Hexcel
$47.09 /

-1.235 (-2.56%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

STLD Steel Dynamics
$38.37 /

-0.35 (-0.90%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

FUL H.B. Fuller
$50.80 /

-1.98 (-3.75%)

CVAC CureVac
$104.31 /

+2.31 (+2.26%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

ASO Academy Sports
$23.70 /

+1.28 (+5.71%)

Hot Stocks
Sarissa Capital reports 5.0% passive stake in BioCryst » 16:46
01/25/21
01/25
16:46
01/25/21
16:46
BCRX

BioCryst

$9.15 /

-0.06 (-0.65%)

Sarissa Capital disclosed…

Sarissa Capital disclosed a 5.0% stake in BioCryst, which represents over 8.84M shares. The filing does not allow for activism.

ShowHide Related Items >><<
BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

12/22/20 JMP Securities
BioCryst selloff today a buying opportunity, says JMP Securities
12/07/20 H.C. Wainwright
BioCryst price target raised to $14 from $13 at H.C. Wainwright
12/04/20 Piper Sandler
BioCryst receives on-time approval with 'clean' label, says Piper Sandler
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

  • 28
    May
BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

BCRX BioCryst
$9.15 /

-0.06 (-0.65%)

Hot Stocks
Dynavax and Medigen announce first dosing in Phase 2 trial of MVC-COV1901 » 08:03
01/25/21
01/25
08:03
01/25/21
08:03
DVAX

Dynavax

$5.22 /

+0.175 (+3.47%)

Medigen Vaccine…

Medigen Vaccine Biologics, or MVC, and Dynavax Technologies (DVAX) announced that the first participant has been dosed in the Phase 2 clinical trial evaluating MVC's COVID-19 vaccine candidate, MVC-COV1901. MVC-COV1901 is a subunit vaccine with recombinant S-2P antigen adjuvanted with CpG 1018 supplied by Dynavax. MVC's Phase 2 clinical trial is a randomized, double-blinded, multi-center clinical trial, expecting to enroll 3,700 healthy subjects, 20 years of age and above. The trial will evaluate MVC-COV1901 safety and endurance of immunogenicity. The proposed dosing regimen is two doses administered intramuscularly one month apart. Based on MVC's Phase 1 interim data, MVC-COV1901 has demonstrated a good safety profile and encouraging immunogenicity performance.

ShowHide Related Items >><<
DVAX Dynavax
$5.22 /

+0.175 (+3.47%)

DVAX Dynavax
$5.22 /

+0.175 (+3.47%)

11/06/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
08/07/20 H.C. Wainwright
Dynavax price target lowered to $12 from $14 at H.C. Wainwright
08/03/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
07/16/20 William Blair
Dynavax has 'attractive asset' in CpG 1018, says William Blair
DVAX Dynavax
$5.22 /

+0.175 (+3.47%)

  • 22
    May
DVAX Dynavax
$5.22 /

+0.175 (+3.47%)

DVAX Dynavax
$5.22 /

+0.175 (+3.47%)

Hot Stocks
Precision BioSciences granted patent for candidate for Non-Hodgkin Lymphoma » 07:07
01/25/21
01/25
07:07
01/25/21
07:07
DTIL

Precision BioSciences

$13.29 /

-0.28 (-2.06%)

Precision BioSciences has…

Precision BioSciences has received a Notice of Allowance from the USPTO for a patent application covering PBCAR19B, a next-generation, stealth cell, CD19 product candidate for patients with relapsed/refractory Non-Hodgkin Lymphoma. The allowed composition claims of the patent application encompass genetically-modified human T cells comprising the company's PBCAR19B construct, which is inserted within the T cell receptor alpha constant locus. Once issued, patents arising from this patent family will have standard expiration dates in April 2040.

ShowHide Related Items >><<
DTIL Precision BioSciences
$13.29 /

-0.28 (-2.06%)

DTIL Precision BioSciences
$13.29 /

-0.28 (-2.06%)

12/15/20 H.C. Wainwright
Precision BioSciences transferred with Buy rating at H.C. Wainwright
12/04/20 Stifel
Precision's PBCAR0191 durability 'a disappointment,' says Stifel
12/04/20 BTIG
Precision BioSciences data provide clear path forward, says BTIG
11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
DTIL Precision BioSciences
$13.29 /

-0.28 (-2.06%)

DTIL Precision BioSciences
$13.29 /

-0.28 (-2.06%)

Recommendations
Citi moves Marvell up to pick in semiconductor equipment » 06:38
01/25/21
01/25
06:38
01/25/21
06:38
MRVL

Marvell

$52.59 /

-0.88 (-1.65%)

, NVDA

Nvidia

$548.55 /

-5.91 (-1.07%)

, LRCX

Lam Research

$563.92 /

-0.27 (-0.05%)

, KLAC

KLA Corp.

$305.02 /

-0.26 (-0.09%)

, ENTG

Entegris

$112.32 /

-1.21 (-1.07%)

, IIVI

II-VI

$93.86 /

+0.58 (+0.62%)

, AMKR

Amkor Technology

$18.46 /

-0.02 (-0.11%)

, CCMP

CMC Materials

$167.54 /

-1.05 (-0.62%)

Citi analyst Atif Malik…

Citi analyst Atif Malik favors semiconductor names over semiconductor capital equipment in the first half of 2021 on peaking wafer fab equipment run rate. He moved Marvell Technology Group (MRVL) to his number one pick and Nvidia (NVDA) to his number two pick. Malik lowered Lam Research (LRCX) and KLA Corp. (KLAC) down by two spots on his ranking list to three and four respectively, On the materials and components group, the analyst maintains Entegris (ENTG) at number one and moves II-VI (IIVI) to his number two pick. He remains Sell rated on Amkor Technology (AMKR) due to long-term margin contraction concerns and CMC Materials (CCMP) due to top line weakness and competitive threats.

ShowHide Related Items >><<
NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

KLAC KLA Corp.
$305.02 /

-0.26 (-0.09%)

IIVI II-VI
$93.86 /

+0.58 (+0.62%)

ENTG Entegris
$112.32 /

-1.21 (-1.07%)

CCMP CMC Materials
$167.54 /

-1.05 (-0.62%)

AMKR Amkor Technology
$18.46 /

-0.02 (-0.11%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

01/25/21 Citi
Marvell price target raised to $64 from $50 at Citi
01/15/21 Susquehanna
Marvell price target raised to $60 from $54 at Susquehanna
01/13/21 Piper Sandler
Marvell price target raised to $60 from $50 at Piper Sandler
01/13/21 Piper Sandler
AMD price target raised to $110 from $100 at Piper Sandler
NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

01/15/21 Truist
Nvidia price target raised to $672 from $643 at Truist
01/15/21 Susquehanna
Nvidia price target raised to $625 from $610 at Susquehanna
01/12/21 Wells Fargo
Nvidia very-well positioned as gaming momentum continues, says Wells Fargo
01/11/21 JPMorgan
NIO Inc. price target raised to $75 from $50 at JPMorgan
LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

01/25/21 Citi
Lam Research price target raised to $660 from $420 at Citi
01/18/21 Goldman Sachs
Lam Research price target raised to $616 from $557 at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
01/08/21
Fly Intel: Top five analyst downgrades
KLAC KLA Corp.
$305.02 /

-0.26 (-0.09%)

01/25/21 Citi
KLA Corp. price target raised to $360 from $236 at Citi
01/18/21 Goldman Sachs
KLA Corp. price target raised to $308 from $271 at Goldman Sachs
01/08/21 Argus
KLA Corp. price target raised to $300 from $235 at Argus
01/06/21 KeyBanc
KLA Corp. price target raised to $293 from $266 at KeyBanc
ENTG Entegris
$112.32 /

-1.21 (-1.07%)

01/25/21 Citi
Entegris price target raised to $135 from $92 at Citi
01/18/21 Goldman Sachs
Entegris price target raised to $116 from $102 at Goldman Sachs
12/14/20 Goldman Sachs
Entegris price target raised to $102 from $89 at Goldman Sachs
12/08/20 Stifel
Entegris price target raised to $115 from $91 at Stifel
IIVI II-VI
$93.86 /

+0.58 (+0.62%)

01/25/21 Citi
II-VI price target raised to $110 from $65 at Citi
01/19/21 Needham
II-VI price target raised to $98 from $71 at Needham
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/18/20 Benchmark
II-VI price target raised to $85 from $65 at Benchmark
AMKR Amkor Technology
$18.46 /

-0.02 (-0.11%)

01/25/21 Citi
Amkor Technology price target raised to $13 from $11.40 at Citi
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment
10/27/20 Deutsche Bank
Amkor Technology price target raised to $16 from $14 at Deutsche Bank
10/19/20 Citi
Citi opens 'positive catalyst watches' on Entegris, Amkor Technology
CCMP CMC Materials
$167.54 /

-1.05 (-0.62%)

01/25/21 Citi
CMC Materials price target raised to $150 from $140 at Citi
01/18/21 Goldman Sachs
CMC Materials upgraded to Neutral from Sell at Goldman Sachs
11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Loop Capital
CMC Materials price target lowered to $170 from $187 at Loop Capital
NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

KLAC KLA Corp.
$305.02 /

-0.26 (-0.09%)

IIVI II-VI
$93.86 /

+0.58 (+0.62%)

ENTG Entegris
$112.32 /

-1.21 (-1.07%)

CCMP CMC Materials
$167.54 /

-1.05 (-0.62%)

AMKR Amkor Technology
$18.46 /

-0.02 (-0.11%)

  • 02
    Jul
NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

IIVI II-VI
$93.86 /

+0.58 (+0.62%)

NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

KLAC KLA Corp.
$305.02 /

-0.26 (-0.09%)

IIVI II-VI
$93.86 /

+0.58 (+0.62%)

AMKR Amkor Technology
$18.46 /

-0.02 (-0.11%)

NVDA Nvidia
$548.55 /

-5.91 (-1.07%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

LRCX Lam Research
$563.92 /

-0.27 (-0.05%)

KLAC KLA Corp.
$305.02 /

-0.26 (-0.09%)

AMKR Amkor Technology
$18.46 /

-0.02 (-0.11%)

Recommendations
Marvell price target raised to $64 from $50 at Citi » 06:31
01/25/21
01/25
06:31
01/25/21
06:31
MRVL

Marvell

$52.59 /

-0.88 (-1.65%)

Citi analyst Atif Malik…

Citi analyst Atif Malik raised the firm's price target on Marvell to $64 from $50 and keeps a Buy rating on the shares. The analyst updated estimates and price targets across semiconductor equipment and components to align with Citi's updated wafer fab equipment estimates and expanded multiples driven by "strong" near term capex spend.

ShowHide Related Items >><<
MRVL Marvell
$52.59 /

-0.88 (-1.65%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

01/15/21 Susquehanna
Marvell price target raised to $60 from $54 at Susquehanna
01/13/21 Piper Sandler
Marvell price target raised to $60 from $50 at Piper Sandler
01/13/21 Piper Sandler
AMD price target raised to $110 from $100 at Piper Sandler
01/12/21 Deutsche Bank
Marvell price target raised to $60 from $50 at Deutsche Bank
MRVL Marvell
$52.59 /

-0.88 (-1.65%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

MRVL Marvell
$52.59 /

-0.88 (-1.65%)

Recommendations
Cinemark price target raised to $16 from $11 at Goldman Sachs » 04:52
01/25/21
01/25
04:52
01/25/21
04:52
CNK

Cinemark

$19.55 /

+0.97 (+5.22%)

Goldman Sachs analyst…

Goldman Sachs analyst Michael Ng raised the firm's price target on Cinemark to $16 from $11 and keeps a Neutral rating on the shares. The analyst cites increased box office forecasts for the target raise.

ShowHide Related Items >><<
CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

01/15/21 B. Riley Securities
B. Riley upgrades Cinemark, doubles target ahead of theater return
01/15/21 MoffettNathanson
Cinemark price target raised to $14 from $12 at MoffettNathanson
01/15/21 B. Riley Securities
Cinemark upgraded to Buy from Neutral at B. Riley Securities
12/28/20 B. Riley Securities
'Wonder Women' opens well above expectations, says B. Riley Securities
CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

Saturday
On The Fly
Charged: Oppenheimer ups Tesla target to Street-high $1,036 » 08:58
01/23/21
01/23
08:58
01/23/21
08:58
TSLA

Tesla

$846.69 /

+1.86 (+0.22%)

, ENPH

Enphase Energy

$212.30 /

+0.21 (+0.10%)

, SEDG

SolarEdge

$321.06 /

+4.01 (+1.26%)

, CLII

Climate Change Crisis Real Impact I

$21.98 /

+8.75 (+66.14%)

, AMZN

Amazon.com

$3,290.00 /

-18.3 (-0.55%)

, F

Ford

$11.52 /

-0.005 (-0.04%)

, WKHS

Workhorse Group

$23.51 /

+0.67 (+2.93%)

, LI

Li Auto

$34.45 /

-0.92 (-2.60%)

, NIO

NIO Inc.

$61.94 /

+3.61 (+6.19%)

, XPEV

Xpeng

$56.36 /

+2.06 (+3.79%)

, PLUG

Plug Power

$66.87 /

+3.2 (+5.03%)

Welcome to The Fly's…

ShowHide Related Items >><<
XPEV Xpeng
$56.36 /

+2.06 (+3.79%)

WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

SEDG SolarEdge
$321.06 /

+4.01 (+1.26%)

PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

NIO NIO Inc.
$61.94 /

+3.61 (+6.19%)

LI Li Auto
$34.45 /

-0.92 (-2.60%)

F Ford
$11.52 /

-0.005 (-0.04%)

ENPH Enphase Energy
$212.30 /

+0.21 (+0.10%)

CLII Climate Change Crisis Real Impact I
$21.98 /

+8.75 (+66.14%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

01/22/21 JPMorgan
JPMorgan boosts target on 'lofty' valued Tesla to $125 from $105
01/22/21 Nomura
Nomura starts 'Tesla-like' NIO with Buy rating, $80.30 price target
01/20/21 JPMorgan
JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous
01/20/21 Deutsche Bank
Tesla price target raised to $890 from $705 at Deutsche Bank
ENPH Enphase Energy
$212.30 /

+0.21 (+0.10%)

01/20/21 JPMorgan
Enphase Energy price target raised to $230 from $199 at JPMorgan
01/20/21 Credit Suisse
Enphase Energy price target raised to $150 from $93 at Credit Suisse
01/19/21 Goldman Sachs
Buy the dip on Enphase Energy after Tesla inverter news, says Goldman Sachs
01/19/21 Piper Sandler
Enphase Energy price target raised to $211 from $150 at Piper Sandler
SEDG SolarEdge
$321.06 /

+4.01 (+1.26%)

01/21/21 Morgan Stanley
SolarEdge initiated with an Overweight at Morgan Stanley
01/20/21 JPMorgan
SolarEdge price target raised to $387 from $371 at JPMorgan
01/20/21 Credit Suisse
SolarEdge price target raised to $284 from $235 at Credit Suisse
CLII Climate Change Crisis Real Impact I
$21.98 /

+8.75 (+66.14%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

01/22/21 Credit Suisse
Amazon.com price target raised to $3,860 from $3,750 at Credit Suisse
01/21/21 BofA
Amazon.com price target raised to $4,000 from $3,650 at BofA
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/11/21 Baird
Baird remains a buyer of Amazon ahead of Q4 results
F Ford
$11.52 /

-0.005 (-0.04%)

01/22/21 JPMorgan
JPMorgan upgrades Ford to Overweight ahead of 'hot new products'
01/22/21 JPMorgan
Ford upgraded to Overweight from Neutral at JPMorgan
01/20/21 Deutsche Bank
Ford price target raised to $11 from $9 at Deutsche Bank
01/20/21 Deutsche Bank
Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

01/04/21 Roth Capital
Roth cautious on Workhorse, says order resembles distribution agreement
12/09/20 Wolfe Research
Workhorse Group initiated with a Peer Perform at Wolfe Research
12/02/20 Roth Capital
USPS delay gives Workhorse competitors more time, says Roth Capital
11/16/20
Workhorse Group initiated with a Buy at Lafferty
LI Li Auto
$34.45 /

-0.92 (-2.60%)

01/19/21
Fly Intel: Top five analyst initiations
01/19/21 Jefferies
Li Auto initiated with a Buy at Jefferies
01/06/21 Credit Suisse
Credit Suisse upgrades Li Auto to Outperform on sales momentum, autonomous plans
01/06/21 Credit Suisse
Li Auto upgraded to Outperform from Neutral at Credit Suisse
NIO NIO Inc.
$61.94 /

+3.61 (+6.19%)

01/22/21
Fly Intel: Top five analyst initiations
01/22/21 Nomura
NIO Inc. initiated with a Buy at Nomura
01/21/21 Deutsche Bank
Deutsche puts short-term buy on Xpeng ahead of 'several catalysts'
XPEV Xpeng
$56.36 /

+2.06 (+3.79%)

01/21/21 Deutsche Bank
Xpeng named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/19/21 Jefferies
Xpeng initiated with a Hold at Jefferies
01/04/21 Citi
Xpeng partnership with Livox is 'very positive,' says Citi
PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

01/14/21 JPMorgan
Plug Power initiated with a Neutral at JPMorgan
01/13/21 B. Riley Securities
Plug Power price target raised to $79 from $52 at B. Riley Securities
01/13/21 Craig-Hallum
Plug Power price target raised to $79 from $60 at Craig-Hallum
01/13/21 H.C. Wainwright
Plug Power price target raised to $85 from $60 at H.C. Wainwright
XPEV Xpeng
$56.36 /

+2.06 (+3.79%)

WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

SEDG SolarEdge
$321.06 /

+4.01 (+1.26%)

PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

NIO NIO Inc.
$61.94 /

+3.61 (+6.19%)

LI Li Auto
$34.45 /

-0.92 (-2.60%)

F Ford
$11.52 /

-0.005 (-0.04%)

ENPH Enphase Energy
$212.30 /

+0.21 (+0.10%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
  • 17
    Nov
  • 31
    Aug
  • 27
    Aug
  • 12
    Aug
  • 30
    Jul
  • 11
    Jun
  • 14
    Feb
WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

NIO NIO Inc.
$61.94 /

+3.61 (+6.19%)

LI Li Auto
$34.45 /

-0.92 (-2.60%)

F Ford
$11.52 /

-0.005 (-0.04%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

XPEV Xpeng
$56.36 /

+2.06 (+3.79%)

WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

SEDG SolarEdge
$321.06 /

+4.01 (+1.26%)

PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

LI Li Auto
$34.45 /

-0.92 (-2.60%)

F Ford
$11.52 /

-0.005 (-0.04%)

ENPH Enphase Energy
$212.30 /

+0.21 (+0.10%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

XPEV Xpeng
$56.36 /

+2.06 (+3.79%)

WKHS Workhorse Group
$23.51 /

+0.67 (+2.93%)

TSLA Tesla
$846.69 /

+1.86 (+0.22%)

PLUG Plug Power
$66.87 /

+3.2 (+5.03%)

NIO NIO Inc.
$61.94 /

+3.61 (+6.19%)

LI Li Auto
$34.45 /

-0.92 (-2.60%)

F Ford
$11.52 /

-0.005 (-0.04%)

ENPH Enphase Energy
$212.30 /

+0.21 (+0.10%)

AMZN Amazon.com
$3,290.00 /

-18.3 (-0.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.